Succeeds Tom Hoeltgen, who is set to retire in December, 2020
Fertin Pharma, a leading contract development and manufacturing organization (CDMO), has appointed John Stephen as CEO of Tab Labs, its Vancouver-based subsidiary. Stephen has been active in the dietary and supplement field for over 30 years. Fertin, which has four decades of experience and unique capabilities in oral and intra-oral delivery of active ingredients, acquired the Canadian contract tableting company in 2019. Stephen succeeds Tab Labs’ current CEO, Tom Hoeltgen, who is set to retire in December, 2020
“The appointment of John, who has worked for some of the largest and most well-managed companies in Canada, is a clear reflection of the company’s track to become our customers’ trusted partner and a global leader in the development and manufacturing of dosage forms that are pleasurable, convenient and effective for the consumer,” said Søren Birn, CEO of Fertin Pharma. Stephen commence in the Tab Labs CEO on April 15.
Tab Labs is a leader in compressed gum, mints and lozenges. It is one of the largest contract tableting companies in North America, servicing customers within the nutraceutical and confectionery sectors. For Fertin, Tab Labs represents an important bridgehead into the large North American market for dietary supplement ingredients delivered through innovative and convenient systems
“Tab Labs reputation for innovation, quality and people culture are known industry wide,” said Stephen. “I’m honored and greatly appreciate the trust placed in me to be a part of an exciting future together with our current and future customers.”
About Fertin Pharma
Fertin is a Danish contract development and manufacturing organization (CDMO) specializing in innovative oral and intra-oral dosage formats with nutraceutical and pharmaceutical ingredients. The company provides patients and consumers with convenient, pleasurable and efficient delivery formats, based on unique know-how, technological capabilities and consumer insight.
For further information, please visit www.fertin.com
